pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    avutometinib potassium + defactinib hydrochloride
    Avmapki Fakzynja (avutometinib potassium + defactinib hydrochloride)
    Ovarian Cancer$VSTM Verastem, Inc.
  • Phase 3
    axicabtagene ciloleucel
    Yescarta (axicabtagene ciloleucel)
    Diffuse Large B-Cell Lymphoma$GILD GILEAD SCIENCES, INC.
  • Phase 3
    azeliragon
    azeliragon
    Coronavirus Disease 2019 (COVID-19) Cantex Pharmaceuticals Inc
← prev
page 41 of 62
next →
Pain89
Neurology1
  • Phase 2
    azenosertib
    azenosertib [INN]
    Endometrial Cancer$ZNTL Zentalis Pharmaceuticals, Inc.
  • Phase 1
    azercabtagene zapreleucel
    azercabtagene zapreleucel
    Diffuse Large B-Cell Lymphoma Imugene Ltd
  • Phase 2
    azerutamig
    azerutamig [INN]
    Esophageal Cancer Bristol-Myers Squibb Co
  • Marketed
    bacillus calmette-guerin [strain Montreal] vaccine
    Pacis
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B… Shire Pharmaceuticals Inc
  • Phase 2
    bafisontamab
    bafisontamab
    Bile Duct Cancer (Cholangiocarcinoma) EpimAb Biotherapeutics Inc
  • Phase 2
    balstilimab
    balstilimab
    Metastatic Colorectal Cancer$AGEN AGENUS INC
  • Phase 1
    basroparib
    basroparib [INN]
    Colorectal Cancer ST Pharm Co Ltd
  • Marketed
    belinostat
    Beleodaq (belinostat)
    Peripheral T-Cell Lymphomas (PTCL) Acrotech Biopharma Inc
  • Phase 3
    belzupacap sarotalocan
    belzupacap sarotalocan
    Uveal Melanoma$AURA Aura Biosciences, Inc.
  • Marketed
    belzutifan
    Welireg (belzutifan)
    Renal Cell Carcinoma$MRK Merck & Co., Inc.
  • Phase 2
    bemcentinib
    bemcentinib
    Non-Small Cell Lung Cancer Oncoinvent ASA
  • Preclinical
    bendamustine
    bendamustine [INN]
    Chronic Lymphocytic Leukemia (CLL) Exinda Therapeutics LLC
  • Marketed
    bendamustine hydrochloride
    Belrapzo (bendamustine hydrochloride)
    B-Cell Non-Hodgkin Lymphoma Eagle Pharmaceuticals Inc
  • Phase 2
    beroterkib
    beroterkib
    Solid Tumor$MOS MOSAIC CO
  • Phase 1
    besufetamig
    besufetamig [INN]
    Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic L… Ono Pharmaceutical Co Ltd
  • pre_registration
    bevacizumab biosimilar
    Jobevne (bevacizumab-awwb)
    Cervical Cancer Shanghai Henlius Biotech Inc
  • Marketed
    bexarotene
    Targretin (bexarotene)
    Cutaneous T-Cell Lymphoma Bausch Health Americas Inc
  • Phase 2
    bexmarilimab
    Clevegen (bexmarilimab [INN])
    Refractory Acute Myeloid Leukemia Faron Pharmaceuticals Oy
  • pre_registration
    bezuclastinib
    bezuclastinib
    Gastrointestinal Stromal Tumor (GIST)$COGT Cogent Biosciences, Inc.
  • Marketed
    bicalutamide
    Bicalutamide
    Metastatic Prostate Cancer Northstar Rx LLC
  • Phase 3
    bifikafusp alfa + onfekafusp alfa
    Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
    Metastatic Melanoma Philogen SpA
  • Marketed
    binimetinib
    Mektovi (binimetinib)
    Metastatic Melanoma Array BioPharma Inc
  • pre_registration
    binimetinib + encorafenib
    Braftovi + Mektovi (binimetinib + encorafenib)
    Metastatic Colorectal Cancer$PFE PFIZER INC
  • Phase 2
    bintrafusp alfa
    bintrafusp alfa
    Bile Duct Cancer (Cholangiocarcinoma) Merck KGaA
  • Phase 2
    birelentinib
    birelentinib
    Refractory Chronic Lymphocytic Leukemia (CLL) Dizal Pharmaceutical Co Ltd
  • Phase 2
    bisantrene
    Zantrene (bisantrene)
    Refractory Acute Myeloid Leukemia Racura Oncology Ltd
  • Phase 2
    bizaxofusp
    bizaxofusp [INN]
    Recurrent Glioblastoma Multiforme (GBM)$MDNAF Medicenna Therapeutics Corp.